Showing 1 - 19 results of 19 for search 'Jose Mordoh', query time: 0.07s Refine Results
  1. 1
    Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells

    Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells by Estefanía Paula Juliá, Analía Amante, María Betina Pampena, José Mordoh, José Mordoh, José Mordoh, Estrella Mariel Levy

    Published 2018-09-01
    Get full text
    Article
  2. 2
    Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants

    Dissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammato... by María B. Pampena, Holliday C. Cartar, Gerardo Rubén Cueto, Estrella M. Levy, Paula A. Blanco, María M. Barrio, José Mordoh, José Mordoh, José Mordoh

    Published 2018-11-01
    Get full text
    Article
  3. 3
    Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release

    Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release by María B. Pampena, María M. Barrio, Estefanía P. Juliá, Paula A. Blanco, Erika M. von Euw, José Mordoh, José Mordoh, José Mordoh, Estrella Mariel Levy

    Published 2017-10-01
    Get full text
    Article
  4. 4
    An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases

    An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases by Ana Mordoh, Mariana Aris, Ibel Carri, Alicia Inés Bravo, Enrique Podaza, Juan Carlos Triviño Pardo, Gerardo Rubén Cueto, María Marcela Barrio, José Mordoh, José Mordoh, José Mordoh

    Published 2022-04-01
    Get full text
    Article
  5. 5
    Lessons from Cancer Immunoediting in Cutaneous Melanoma

    Lessons from Cancer Immunoediting in Cutaneous Melanoma by Mariana Aris, María Marcela Barrio, José Mordoh

    Published 2012-01-01
    Get full text
    Article
  6. 6
    Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report

    Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report by Mariana Aris, Alicia Inés Bravo, María Betina Pampena, Paula Alejandra Blanco, Ibel Carri, Daniel Koile, Patricio Yankilevich, Estrella Mariel Levy, María Marcela Barrio, José Mordoh, José Mordoh, José Mordoh

    Published 2018-05-01
    Get full text
    Article
  7. 7
    Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer

    Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer by Estefanía Paula Juliá, José Mordoh, Estrella Mariel Levy

    Published 2020-06-01
    Get full text
    Article
  8. 8
    Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood

    Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes T... by Mariana Aris, Alicia Inés Bravo, Heli Magalí Garcia Alvarez, Ibel Carri, Enrique Podaza, Paula Alejandra Blanco, Cecilia Rotondaro, Sofia Bentivegna, Morten Nielsen, Morten Nielsen, María Marcela Barrio, José Mordoh, José Mordoh, José Mordoh

    Published 2019-09-01
    Get full text
    Article
  9. 9
    Phenotypic and functional dysregulated blood NK cells in Colorectal cancer patients can be activated by cetuximab plus IL-2 or IL-15.

    Phenotypic and functional dysregulated blood NK cells in Colorectal cancer patients can be activated by cetuximab plus IL-2 or IL-15. by Yamila Sol Rocca, María Paula Roberti, Estefanía Paula Juliá, María Betina Pampena, Luisina Bruno, Sergio Rivero, Eduardo Huertas, Fernando Sánchez Loria, Alejandro Pairola, Anne Caignard, José Mordoh, José Mordoh, José Mordoh, Estrella Mariel Levy

    Published 2016-10-01
    Get full text
    Article
  10. 10
    Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF

    Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine... by Enrique Podaza, Ibel Carri, Mariana Aris, Erika von Euw, Erika von Euw, Alicia Inés Bravo, Paula Blanco, Juan Manuel Ortiz Wilczyñski, Daniel Koile, Patricio Yankilevich, Morten Nielsen, Morten Nielsen, José Mordoh, José Mordoh, José Mordoh, María Marcela Barrio

    Published 2020-06-01
    Get full text
    Article
  11. 11
    Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study

    Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study by José Mordoh, Erika Schwab, Alicia Inés Bravo, Mariana Aris, María Marcela Barrio

    Published 2024-04-01
    Get full text
    Article
  12. 12
    Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report

    Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report by Ana Mordoh, Juan Carlos Triviño Pardo, Ibel Carri, María Marcela Barrio, José Mordoh, Mariana Aris

    Published 2023-01-01
    Get full text
    Article
  13. 13
    miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool

    miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool by María Sol Ruiz, María Belén Sánchez, Simone Bonecker, Carolina Furtado, Daniel Koile, Patricio Yankilevich, Santiago Cranco, María del Rosario Custidiano, Josefina Freitas, Beatriz Moiraghi, Mariel Ana Pérez, Carolina Pavlovsky, Ana Inés Varela, Verónica Ventriglia, Julio César Sánchez Ávalos, Irene Larripa, Ilana Zalcberg, José Mordoh, José Mordoh, José Mordoh, Peter Valent, Peter Valent, Michele Bianchini

    Published 2021-01-01
    Get full text
    Article
  14. 14
    Beyond MHC binding: immunogenicity prediction tools to refine neoantigen selection in cancer patients

    Beyond MHC binding: immunogenicity prediction tools to refine neoantigen selection in cancer patients by Ibel Carri, Erika Schwab, Enrique Podaza, Heli M. Garcia Alvarez, José Mordoh, Morten Nielsen, María Marcela Barrio

    Published 2023-04-01
    Get full text
    Article
  15. 15
    HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy

    HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immu... by Alicia Inés Bravo, Alicia Inés Bravo, Mariana Aris, Marylou Panouillot, Marylou Panouillot, Marylou Panouillot, Martina Porto, Marie-Caroline Dieu-Nosjean, Marie-Caroline Dieu-Nosjean, Marie-Caroline Dieu-Nosjean, Jean-Luc Teillaud, Jean-Luc Teillaud, Jean-Luc Teillaud, María Marcela Barrio, José Mordoh, José Mordoh

    Published 2023-08-01
    Get full text
    Article
  16. 16
    VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens

    VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens by Ibel Carri, Ibel Carri, Erika Schwab, Juan Carlos Trivino, Erika M. von Euw, Morten Nielsen, Morten Nielsen, José Mordoh, María Marcela Barrio

    Published 2025-01-01
    Get full text
    Article
  17. 17
    Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.

    Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells. by María Marcela Barrio, Riad Abes, Marina Colombo, Gabriela Pizzurro, Charlotte Boix, María Paula Roberti, Emmanuelle Gélizé, Mariana Rodriguez-Zubieta, José Mordoh, Jean-Luc Teillaud

    Published 2012-01-01
    Get full text
    Article
  18. 18
    In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy

    In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy by María Belén Sanchez, Bianca Vasconcelos Cordoba, Carolina Pavlovsky, Beatriz Moiraghi, Ana Varela, Rosario Custidiano, Isolda Fernandez, María Josefina Freitas, María Verónica Ventriglia, Georgina Bendek, Romina Mariano, María José Mela Osorio, Miguel Arturo Pavlovsky, Ana García de Labanca, Cecilia Foncuberta, Isabel Giere, Masiel Vera, Mariana Juni, José Mordoh, Julio Cesar Sanchez Avalos, Estrella Mariel Levy, Michele Bianchini

    Published 2023-09-01
    Get full text
    Article
  19. 19
    Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal

    Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal by Carolina Pavlovsky, Bianca Vasconcelos Cordoba, María Belén Sanchez, Beatriz Moiraghi, Ana Varela, Rosario Custidiano, Isolda Fernandez, Maria Josefina Freitas, Maria Verónica Ventriglia, Georgina Bendek, Romina Mariano, María José Mela Osorio, Miguel Angel Pavlovsky, Ana García de Labanca, Cecilia Foncuberta, Isabel Giere, Masiel Vera, Mariana Juni, Jose Mordoh, Julio Cesar Sanchez Avalos, Gerardo Cueto, Silvia Miranda, Estrella Mariel Levy, Michele Bianchini

    Published 2023-04-01
    Get full text
    Article

Search Tools: